Effects of interleukin-6, interleukin-18, and statin use, evaluated at acute stroke, on post-stroke depression during 1-year follow-up

Psychoneuroendocrinology

Volumn 72, Issue , 2016, Pages 156-160

  Kang, Hee Ju ^a   Bae, Kyung Yeol ^a   Kim, Sung Wan ^a   Kim, Joon Tae ^a   Park, Man Seok ^a   Cho, Ki Hyun ^a   Kim, Jae Min ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Cytokine; Depression; Longitudinal study; Statin; Stroke

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18; INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ACUTE DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; DSM-IV; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; BLOOD; COMPLICATION; MAJOR DEPRESSION;

DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-18; INTERLEUKIN-6; STROKE;

EID: 84978791271     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2016.07.001     Document Type: Article

References (20)

1. Anisman, H., Kokkinidis, L., Merali, Z., Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav. Immun. 16 (2002), 544–556.
2. Antonopoulos, A.S., Margaritis, M., Lee, R., Channon, K., Antoniades, C., Statins as anti-inflmmatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr. Pharm. Des. 18 (2012), 1519–1530.
3. Felderhoff-Mueser, U., Schmidt, O.I., Oberholzer, A., Buhrer, C., Stahel, P.F., IL-18: a key player in neuroinflammation and neurodegeneration?. Trends Neurosci. 28 (2005), 487–493.
4. Folstein, M.F., Fostein, S.E., McHugh, P.R., “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975), 189–198.
5. Kasner, S.E., Chalela, J.A., Luciano, J.M., Cucchiara, B.L., Raps, E.C., McGarvey, M.L., Conroy, M.B., Localio, A.R., Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 30 (1999), 1534–1537.
6. Kim, J.M., Stewart, R., Park, M.S., Kang, H.J., Kim, S.W., Shin, I.S., Kim, H.R., Shin, M.G., Cho, K.H., Yoon, J.S., Associations of BDNF genotype and promoter methylation with acute and longterm stroke outcomes. PLoS One, 7, 2012, e51280.
7. Kutlubaev, M.A., Hackett, M.L., Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. Int. J. Stroke 9 (2014), 1026–1036.
8. Maes, M., Verkerk, R., Bonaccorso, S., Ombelet, W., Bosmans, E., Scharpé, S., Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine: a phenomenon which is related to immune activation. Life Sci. 71 (2002), 1837–1848.
9. Parsaik, A.K., Singh, B., Murad, M.H., Singh, K., Mascarenhas, S.S., Williams, M.D., Lapid, M.I., Richardson, J.W., West, C.P., Rummans, T.A., Statin use and risk of depression: a systematic review and meta-analysis. J. Affect. Disord. 160 (2014), 62–67.
10. Sacco, R.L., Adams, R., Albers, G., Alberts, M.J., Benavente, O., Furie, K., Goldstein, L.B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S.C., Katzan, I., Kelly-Hayes, M., Kenton, E.J., Marks, M., Schwamm, L.H., Tomsick, T., American Heart Association/American Stroke Association Council on Stroke, Council on Cardiovascular Radiology and Intervention, American Academy of Neurology, Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006), 577–617.
11. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, G.C., The mini-international neuropsychiatric interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-VI and ICD-10. J. Clin. Psychiatry 59 (1988), 22–33.
12. Spalletta, G., Bossù, P., Ciaramella, A., Bria, P., Caltaqirone, C., Robinson, R.G., The etiology of poststroke depression: a review of the literature and new hypothesis involving inflammatory cytokines. Mol. Psychiatry 11 (2006), 984–991.
13. Spalletta, G., Cravello, L., Imperiale, F., Salani, F., Bossù, P., Picchetto, L., Cao, M., Rasura, M., Pazzelli, F., Orzi, F., Caltagirone, C., Robinson, R.G., Cacciari, C., Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J. Neuropsychiatry Clin. Neurosci. 25 (2013), 255–263.
14. Stafford, L., Berk, M., The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypothesis of depression. J. Clin. Psychiatry 72 (2011), 1229–1235.
15. Su, J.A., Chou, S.Y., Tsai, C.S., Hung, T.H., Cytokine changes in the pathophysiology of poststroke depression. Gen. Hosp. Psychiatry 34 (2012), 35–39.
16. Taraz, M., Khatami, M.R., Dashti-Khavidaki, S., Akhonzadeh, S., Noorbala, A.A., Ghaeli, P., Taraz, S., Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial. Int. Immunopharmacol. 17 (2013), 917–923.
17. Turnbull, A.V., Rivier, C.L., Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79 (1999), 1–71.
18. Yang, L., Zhang, Z., Sun, D., Xu, Z., Zhang, X., Li, L., The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurol. Res. 32 (2010), 340–346.
19. Yudkin, J.S., Kumari, M., Humphries, S.E., Mohamed-Ali, V., Inflammation, obesity, stress and coronary heart disease: is interlekin-6 the link?. Atherosclerosis 148 (2001), 209–214.
20. Zaremba, J., Losy, J., Interleukin-18 in acute ischaemic stroke patients. Neurol. Sci. 24 (2003), 117–124.